for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Olympus Corp

7733.T

Latest Trade

1,940.00JPY

Change

8.00(+0.41%)

Volume

3,790,500

Today's Range

1,916.50

 - 

1,967.50

52 Week Range

1,162.00

 - 

2,148.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
1,932.00
Open
1,941.00
Volume
3,790,500
3M AVG Volume
84.62
Today's High
1,967.50
Today's Low
1,916.50
52 Week High
2,148.00
52 Week Low
1,162.00
Shares Out (MIL)
1,285.59
Market Cap (MIL)
2,582,118.00
Forward P/E
73.41
Dividend (Yield %)
0.53

Next Event

Q1 2021 Olympus Corp Earnings Release

Latest Developments

More

Olympus Corp - To Postpone Announcement Of Financial Forecasts For Fy2020/21Originally Scheduled For June 24

FDA Recommends Health Care Facilities, Manufacturers Transition To Duodenoscopes With Disposable Components

Olympus Corp - Received Request From Individual Shareholder To Sue Auditor Kpmg Azsa Llc For 88.67 Billion Yen For Past Breach Of Duty

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Olympus Corp

Olympus Corporation is mainly engaged in the manufacture and sales of medical equipment. The Company operates in four business segments. The Medical segment is engaged in the manufacture and sale of gastrointestinal endoscope, surgical endoscope, endoscopic treatment instrument and ultrasonic endoscope. The Scientific segment is engaged in the manufacture and sale of biological microscope, industrial microscope, industrial endoscope and non-destructive inspection equipment. The Imaging segment is engaged in the manufacture and sale of digital cameras and recording machines. The Others segment is engaged in the manufacture and sale of biomaterials. The Company is also engaged in the financial investment business.

Industry

Medical Equipment & Supplies

Contact Info

Shinjuku Monolith, 2-3-1, Nishi-Shinjuku

SHINJUKU-KU, TKY

163-0914

Japan

+81.3.33402111

https://www.olympus.co.jp/

Executive Leadership

Yasuo Takeuchi

President, Chief Executive Officer, Representative Executive Officer, Director

Yasushi Sakai

Executive Officer, Chief Financial Officer, Chief Improvement Officer

Akihiro Taguchi

Executive Officer, Chief Operating Officer, President of Subsidiary

Haruo Ogawa

Executive Officer, Chief Technology Officer

Stefan Kaufmann

Chief Administrative Officer, Executive Officer, Director

Key Stats

2.00 mean rating - 13 analysts
Sell
Hold
Buy
Revenue (MM, JPY)

2018

0.8K

2019

0.8K

2020

0.8K

2021(E)

0.7K
EPS (JPY)

2018

41.710

2019

5.970

2020

39.370

2021(E)

25.657
Price To Earnings (TTM)
47.87
Price To Sales (TTM)
3.24
Price To Book (MRQ)
6.53
Price To Cash Flow (TTM)
21.52
Total Debt To Equity (MRQ)
75.77
LT Debt To Equity (MRQ)
53.92
Return on Investment (TTM)
7.80
Return on Equity (TTM)
5.30

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up